Clinical Trial Update: Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial comparing paclitaxel/cisplatin versus cisplatin/5-fluorouracil in neoadjuvant chemoradiation for esophageal squamous cell carcinoma; status cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Cisplatin/5-fluorouracil
• Paclitaxel/Cisplatin

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Esophageal Squamous Cell Carcinoma, Chemoradiation | Phase 2, Phase 3 | Status: UNKNOWN